Amgen Inc (AMGN)
266.87
+4.12
(+1.57%)
USD |
NASDAQ |
Apr 19, 12:46
Amgen Net Income (TTM): 6.717B for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 6.717B |
September 30, 2023 | 7.566B |
June 30, 2023 | 7.979B |
March 31, 2023 | 7.917B |
December 31, 2022 | 6.552B |
September 30, 2022 | 6.835B |
June 30, 2022 | 6.576B |
March 31, 2022 | 5.723B |
December 31, 2021 | 5.893B |
September 30, 2021 | 5.609B |
June 30, 2021 | 5.746B |
March 31, 2021 | 7.085B |
December 31, 2020 | 7.264B |
September 30, 2020 | 7.352B |
June 30, 2020 | 7.299B |
March 31, 2020 | 7.675B |
December 31, 2019 | 7.842B |
September 30, 2019 | 8.067B |
June 30, 2019 | 7.958B |
March 31, 2019 | 8.075B |
December 31, 2018 | 8.394B |
September 30, 2018 | 2.202B |
June 30, 2018 | 2.364B |
March 31, 2018 | 2.219B |
December 31, 2017 | 1.979B |
Date | Value |
---|---|
September 30, 2017 | 8.178B |
June 30, 2017 | 8.174B |
March 31, 2017 | 7.893B |
December 31, 2016 | 7.722B |
September 30, 2016 | 7.587B |
June 30, 2016 | 7.433B |
March 31, 2016 | 7.216B |
December 31, 2015 | 6.939B |
September 30, 2015 | 6.433B |
June 30, 2015 | 5.814B |
March 31, 2015 | 5.708B |
December 31, 2014 | 5.158B |
September 30, 2014 | 4.885B |
June 30, 2014 | 5.009B |
March 31, 2014 | 4.72B |
December 31, 2013 | 5.081B |
September 30, 2013 | 4.848B |
June 30, 2013 | 4.587B |
March 31, 2013 | 4.595B |
December 31, 2012 | 4.345B |
September 30, 2012 | 4.491B |
June 30, 2012 | 3.838B |
March 31, 2012 | 3.742B |
December 31, 2011 | 3.683B |
September 30, 2011 | 3.771B |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
5.609B
Minimum
Sep 2021
8.067B
Maximum
Sep 2019
7.034B
Average
7.264B
Median
Dec 2020
Net Income (TTM) Benchmarks
Gilead Sciences Inc | 5.664B |
Johnson & Johnson | 40.58B |
Eli Lilly and Co | 5.240B |
Merck & Co Inc | 365.00M |
Vertex Pharmaceuticals Inc | 3.620B |